PCN3 POPULATION-BASED BUDGET IMPACT MODEL OF APREPITANT (EMEND) IN HIGHLY EMETOGENIC CISPLATINE-BASED CHEMOTHERAPY
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67241-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)67241-5/fulltext
Section Title :
Section Order :
468
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67241-5&doi=10.1016/S1098-3015(10)67241-5